Manufacture of bulk drugs at the heart of what we do
India’s first company to start commercial production of Anti-tuberculosis drug Rifampicin
Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.
News Corner
2021-09-19 21:55:00 - Proceeding of 40th A.G.M
2021-09-19 21:53:00 - Disclosure under Reg 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
2021-09-19 21:52:00 - Disclosure under Regulation 10(6) SAST - PBG
2021-09-19 09:51:47 - Disclosure under Regulation 29(2) of SEBI (SAST) Regulation-2011
2021-09-18 21:47:00 - Resignation of Directors nominated by YUHAN
Annual Report 2020 – 2021